Viewing Study NCT00950768


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-29 @ 4:06 PM
Study NCT ID: NCT00950768
Status: COMPLETED
Last Update Posted: 2009-08-03
First Post: 2009-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Sponsor: Azienda Ospedaliera San Giovanni Battista
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module